BOUNDARY HOUSE MEDICAL CENTRE — All Prescriptions & Medications — Page 4
Practice Code: P91013 | SALE, M33 2RH
Showing results 151-200 of 606
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Nicorandil | 292 | 10.7K | £1.4K | +102.8% ▲ |
| Betahistine hydrochloride | 291 | 22.3K | £895 | +21.9% ▲ |
| Oxybutynin | 290 | 13.9K | £736 | +52.2% ▲ |
| Sacubitril/valsartan | 282 | 11.5K | £18.8K | +17.8% ▲ |
| Zonisamide | 281 | 7,084 | £3.7K | +544.1% ▲ |
| Trimethoprim | 276 | 9,483 | £587 | +35.1% ▲ |
| Dexamethasone | 275 | 1,495 | £932 | +59.9% ▲ |
| Progesterone | 274 | 28.5K | £5.9K | -34.5% ▼ |
| Clonazepam | 269 | 7,119 | £914 | +72.6% ▲ |
| Fluticasone furoate | 268 | 309 | £2.0K | +38.3% ▲ |
| Calcipotriol | 268 | 27.5K | £14.5K | +57.4% ▲ |
| Linagliptin | 265 | 6,370 | £7.2K | -35.3% ▼ |
| Risperidone | 263 | 7,484 | £422 | +4.0% ▲ |
| Ispaghula husk | 262 | 16.0K | £2.7K | +98.9% ▲ |
| Budesonide | 262 | 331 | £8.0K | -51.7% ▼ |
| Irbesartan | 260 | 7,504 | £323 | +6.7% ▲ |
| Topiramate | 251 | 16.3K | £770 | +41.2% ▲ |
| Estradiol | 246 | 7,842 | £4.0K | -8.8% ▼ |
| Dorzolamide and timolol | 244 | 2,355 | £3.4K | +70.5% ▲ |
| Letrozole | 243 | 9,854 | £885 | +30.1% ▲ |
| Sodium valproate | 242 | 27.9K | £3.5K | -23.9% ▼ |
| 242 | 267 | £1.6K | +2.4% ▲ | |
| Clotrimazole | 241 | 2,318 | £2.0K | +118.4% ▲ |
| Mesalazine (Systemic) | 240 | 31.5K | £16.2K | +0.2% vs avg |
| Co-careldopa (Carbidopa/levodopa) | 239 | 26.4K | £1.5K | +5.8% ▲ |
| Fusidic acid | 233 | 5,310 | £658 | +82.5% ▲ |
| Lithium carbonate | 230 | 4,212 | £640 | +81.3% ▲ |
| Lercanidipine hydrochloride | 229 | 9,940 | £1.1K | -62.9% ▼ |
| Beclometasone dipropionate | 229 | 261 | £750 | +6.5% ▲ |
| Glyceryl trinitrate | 228 | 232 | £509 | -3.6% ▼ |
| Cefalexin | 228 | 7,271 | £489 | +96.0% ▲ |
| Methylprednisolone acetate | 228 | 233 | £928 | +97.5% ▲ |
| Aciclovir | 227 | 11.2K | £767 | +52.6% ▲ |
| Fentanyl | 222 | 2,022 | £6.9K | +116.7% ▲ |
| Clobetasol propionate | 222 | 18.6K | £1.4K | +62.7% ▲ |
| Empagliflozin/metformin | 214 | 17.2K | £10.7K | +311.0% ▲ |
| Quinine sulfate | 213 | 4,389 | £649 | -26.4% ▼ |
| Sitagliptin | 213 | 8,816 | £649 | -45.4% ▼ |
| Methotrexate | 213 | 5,808 | £347 | -34.6% ▼ |
| 213 | 6,010 | £2.0K | +175.4% ▲ | |
| 209 | 21.9K | £1.0K | +285.1% ▲ | |
| Pantoprazole | 206 | 7,301 | £344 | -25.1% ▼ |
| Hydroxychloroquine sulfate | 205 | 7,967 | £372 | +5.9% ▲ |
| Carbomer 940/980 | 204 | 4,350 | £890 | +34.0% ▲ |
| Bisacodyl | 201 | 4,901 | £361 | +53.4% ▲ |
| Tiotropium bromide | 197 | 5,024 | £7.6K | -35.2% ▼ |
| Lidocaine hydrochloride | 196 | 2,074 | £2.3K | +13.6% ▲ |
| Carvedilol | 195 | 8,764 | £306 | +71.9% ▲ |
| Miconazole nitrate | 193 | 8,350 | £1.3K | +172.8% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 192 | 232 | £3.3K | +69.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.